An in vivo tumor xenograft assay showed that the HDAC inhibitor JNJ-26,481,585 strongly induced pan-H3 acetylation in tumor tissues and fully inhibited the growth of C170HM2 colorectal liver metastases[41]. Here, HDAC9 is linked to neoplasm.